Top Markets
Coin of the day
AEON Biopharma, Inc. AEON Biopharma, Inc.

AEON Biopharma, Inc.

AEON
Rang in Aktien #31959
AEON Biopharma, Inc. is a biopharmaceutical company primarily engaged in... AEON Biopharma, Inc. is a biopharmaceutical company primarily engaged in developing therapies based on botulinum toxins, aimed at treating various debilitating medical conditions. Among its key investigational products is ABP-450, a 900 kDa botulinum toxin complex, which is being advanced for therapeutic use in conditions such as migraine, cervical dystonia, and gastroparesis. The entity, originally known as ALPHAEON Corporation, adopted the name AEON Biopharma, Inc. in December 2019. Established in 2012, the company maintains its principal operations from Newport Beach, California.
Aktienkurs
$0.262
Zuletzt synchronisiert: 2026-08-17
Marktkapitalisierung
$11.57M
Veränderung (1 Tag)
-5.00%
Veränderung (1 Jahr)
-65.30%
Land
US
Handel AEON Biopharma, Inc. (AEON)

Kategorie

Kursverlauf für AEON Biopharma, Inc. (AEON)
Höchster Schlusskurs: $0.27 am 2026-08-01

Niedrigster Schlusskurs: $523.20 am 2023-07-01
Kursverlauf der Aktie von AEON Biopharma, Inc. von 2023 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) -4.70%
2025 -98.03%
2024 -89.48%
2023 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$515.58 32.24%
US
$992.01 50.00%
NL
$111.75 -36.57%
AU
$736.64 6.99%
CH
$1.06K -7.22%
KR